Ozone-based eye drops in anterior segment pathologies: rationale and pre-clinical data


https://doi.org/10.4081/ozone.2017.6743
3
0
8
0
Smart Citations
3
0
8
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Authors

  • Andrea Marchegiani
    andrea.marchegiani@unicam.it
    School of Biosciences and Veterinary Medicine, University Hospital of Educational Veterinary Sciences, University of Camerino, Italy.
  • Andrea Spaterna School of Biosciences and Veterinary Medicine, University Hospital of Educational Veterinary Sciences, University of Camerino, Italy.
Inflammatory anterior segment diseases necessitating adequate antinflammatory therapy as conjunctivitis, keratoconjunctivitis sicca and corneal ulcers are common eye disorders encountered both in humans and in animals, actually treated by topical administration of eye drops containing antinflammatory and antibacterial agents. The current molecules often lack efficacy because infections in hypoxic tissue contain methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa and new products for the treatment of ocular pain and inflammation are need. The use of ozone in certain anterior segment pathologies could be providential due to anti-inflammatory and bactericidal activity, in addition to promoting tissue repair properties. Ozonated oils have the same properties of gaseous ozone and are well tolerated by tissues. In the present study ozone-based eye drops were used to treat recurrent conjunctivitis and keratitis with excellent results in terms of pathology resolutions and satisfaction of the owners.